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 2 
ABSTRACT 1 
 2 
The σ54-dependent prokaryotic regulator XylR implements a one-input / one-output actuator that 3 
transduces the presence of the aromatic effector m-xylene into transcriptional activation of the cognate 4 
promoter Pu. Such a signal conversion involves the effector-mediated release of the intramolecular 5 
repression of the N-terminal A domain on the central C module of XylR. On this background, we set out 6 
to endow this regulator with additional signal-sensing capabilities by inserting a target site of the viral 7 
protease NIa in permissive protein locations that once cleaved in vivo could either terminate XylR 8 
activity or generate an effector-independent, constitutive transcription factor. To find optimal protein 9 
positions to this end we saturated the xylR gene DNA with a synthetic transposable element designed 10 
for randomly delivering in-frame polypeptides throughout the sequence of any given protein. This Tn5-11 
based system supplies the target gene with insertions of a selectable marker that can later be excised 12 
leaving behind the desired (poly) peptides grafted into the protein structure. Implementation of such 13 
knock-in / leave behind (KILB) method to XylR was instrumental to produce a number of variants of this 14 
TF that could compute in vivo two inputs (m-xylene and protease) into a single output following a logic 15 
that was dependent on the site of the insertion of the NIa target sequence in the TF.  Such NIa-sensitive 16 
XylR specimens afforded the design of novel regulatory nodes that entered protease expression as one 17 
of signals recognized in vivo for controlling Pu. This approach is bound to facilitate the functionalization 18 
of TFs and other proteins with new traits, especially when their forward engineering is made difficult by, 19 
for example, the absence of structural data. 20 
__________________________________________________________________________________ 21 
 22 
INTRODUCTION 23 
 24 
Promoters are the basic molecular devices that translate given physicochemical signals into decision to 25 
start transcription of specific DNA sequences into mRNA1. Regulation of this process in bacteria is 26 
typically mediated by transcriptional factors that either trigger (activators) or inhibit (repressors) the 27 
action of RNA polymerase on DNA motifs that are bound on the basis of the sigma factor included in the 28 
enzyme2. The many possibilities of interplay between different TFs, the RNAP, and the target DNA 29 
originate a considerable plasticity both in terms of the input/output logic of the regulatory nodes at stake 30 
and its kinetic properties. Both the logic structure and the parameters embodied in each singular 31 
 3 
promoter often appear connected to other regulatory devices of the kind to form complex genetic 1 
networks which ultimately rule the lifestyle of the bacteria that host them3. 2 
 3 
Virtually all known prokaryotic promoters can be described with Boolean formalisms under which each 4 
regulatory event results from the action of one or more binary gates which compute up to two inputs into 5 
a single output with a pre-fixed logic1. Similarity of such logic circuits to electronic networks has 6 
stimulated the design of gates artificially assembled with prokaryotic regulatory parts that can process 7 
specific signals and can be combined with others for implementing simple computations4. The repertoire 8 
of such regulatory devices is typically limited to existing TFs and cognate promoters. The latter can be 9 
easily engineered to contain binding sites in positions which make transcriptional output to follow 10 
different outcomes depending on the signal-responsive properties of the transcription factors employed 11 
in the design5. Interestingly, most prokaryotic promoters compute signals on the mere basis of binding 12 
(or lack of it) of cognate TFs to DNA2. In contrast, extant TFs do not perform any binary computation by 13 
themselves, but they simply transduce one signal (e.g. effector binding) into another (e.g. a 14 
conformational change) that may result in productive attachment to the target promoter. Activators thus 15 
intrinsically implement a YES gate while repressors execute a NOT gate1. Dependency of such activities 16 
on small effector molecules allows their connection for the sake of growingly complex gates and circuits. 17 
Yet, the question at stake is whether one could artificially make single TFs not just to transduce single 18 
signals but to compute two inputs with a predetermined logic –thus converting the TF itself (and not its 19 
binding to DNA) in the executor of the desired logic operation6,7. But what TF or TF family could be 20 
optimal to this end? In this work, we advocate prokaryotic activators that depend on the alternative 21 
sigma factor σ54  as the platform of choice8 for artificially endowing new-to-nature possibilities to the 22 
logic of bacterial promoters.  23 
 24 
TFs that act in concert with σ54 (also known as prokaryotic enhancer-binding proteins or NtrC-type 25 
regulators) have a distinct modular structure that includes an amino-terminal, signal-reception region (A 26 
domain), the hinge B domain which places the A domain in a position that allows or not transcriptional 27 
activation, the central C domain responsible for binding and hydrolysis of the ATP and interactions with 28 
σ54 and the C-terminal D domain, which binds DNA9. In a group of such TFs, the A domain represses 29 
the ATPase activity of the TF in the absence of the activating signal (typically a small effector molecule). 30 
TFs of this type are involved in different physiological processes, e.g. metabolism of aromatic 31 
 4 
compounds (XylR, DmpR, HbpR, TbuT and PhhR), formate metabolism (FhlA), nitrogen fixation  (NifA), 1 
acetoin catabolism (AcoR), transport systems (DctD), and others10. In the case of the  XylR regulator of 2 
the TOL pathway of Pseudomonas putida mt-210,11, the A domain interacts directly with the aromatic 3 
effector m-xylene, an event that results in the release of the intramolecular repression (or anti-4 
activation) caused by the A domain itself on the rest of the protein. As a consequence, XylR variants 5 
deleted of the A module (XylR∆A) are constitutively active12,13. XylR plus m-xylene (or XylR∆A) then 6 
activates the target σ54-promoter Pu in concert with a number of DNA binding proteins that endows the 7 
regulatory node with a complex logic14. However, XylR acts in this system only as a mere one-input/ 8 
one-output actuator that translates the presence of m-xylene into a protein form able to activate 9 
transcription. Inspection of the XylR domain structure and its activation mechanism (Fig. 1) suggested 10 
that it would be possible to produce TF variants with an expanded logic repertoire if the protein could be 11 
conditionally cleaved in a fashion that either destroyed its activity altogether or deleted the A domain 12 
and originated an effector-independent, constitutively active regulator.  13 
 14 
The results below describe the design and implementation of a new molecular tool for functionalization 15 
of target proteins (e.g. XylR) with novel properties brought about by insertion of purposeful polypeptides 16 
at otherwise permissive sites of its primary sequence. The tool is based on the in vitro saturation of the 17 
TF-coding DNA with a synthetic transposon that, after insertion and selection, can be excised leaving 18 
behind an in-frame functional sequence of choice (for example, a specific protease cleaving site), which 19 
can be tested for permissiveness in vivo. Application of this tool to XylR originated TF variants that 20 
responded either positively or negatively to expression of such protease, which could then be entered 21 
as one of the inputs of the system in live cells. The resulting TFs implemented by themselves a suite of 22 
non-natural logic actions that have no precedents in extant prokaryotic regulators and thus expand the 23 
repertoire of prokaryotic devices available for engineering logic circuits. Since XylR originates in a 24 
system for catabolism of m-xylene, its functionalized variants have an especial value for programming 25 
bacteria aimed at bioremediation of environmental pollutants.  26 
 27 
RESULTS AND DISCUSSION 28 
 29 
Rationale for creating logic gates based on XylR. The domain structure and the mechanism of action 30 
of XylR on its cognate promoters Pu and PR of the TOL plasmid pWW0 of P. putida mt-2 are sketched in 31 
 5 
Fig. 1. Three features of the process are worth considering for the sake of this work. First, unlike most 1 
prokaryotic TFs, this regulatory proteins is clearly composed of 3 distinct domains: the N-terminus 2 
module, which interacts directly with the aromatic effector m-xylene (or some structural analogues), the 3 
central C domain contacts and activates the sigma factor σ54 of RNAP for recognition and eventual 4 
formation of an open complex at the -12/-24 DNA motif that is typical of this type of promoters, and the 5 
C-terminal helix-turn-helix part (D domain) for binding upstream sequences12,15. The A and C domains 6 
are connected by a small hinge B sequence. XylR is thus a complete actuator that transforms an input 7 
signal (m-xylene) into eventual motion of the RNAP. The other components necessary for transcription 8 
initiation (promoter DNA, ATP, IHF, and additional nucleoid-associated proteins) can be considered not 9 
to vary and thus can be abstracted with a default value16. The second unique feature of XylR and other 10 
TFs of its class is that the mechanism of activation by m-xylene involves the release of an intra-11 
molecular occlusion exerted by the effector-binding A domain on the C domain12,13. This makes deletion 12 
of the N-terminus of XylR to produce an effector-independent constitutive variant, which –for the sake of 13 
Pu activation is equivalent to the wild-type protein in the presence of m-xylene. Finally, XylR can also 14 
act as a repressor of its own synthesis, because it binds also sequences of the TOL plasmid that 15 
overlap the σ70 promoter PR for transcription of the xylR gene17.  16 
 17 
The logic structure of such a regulatory device of the TOL plasmid is shown in Fig. 1. Perusal of the 18 
primary sequence of XylR immediately suggested that it would be possible to enter an additional input 19 
to the system by inserting specific protease-cutting sites at strategically located spots of the protein 20 
structure, provided that they did not alter TF activity in the absence of cleavage. While many locations 21 
could be predicted to terminate XylR function upon proteolysis, those able to excise the A domain from 22 
the rest of the protein could in fact activate this TF with a different mechanism than that caused by 23 
exposure to m-xylene. These scenarios open the possibility of having the same TF responding to two 24 
entirely independent inputs (m-xylene and protease) and the output to have an opposite sign reliant on 25 
the site of the XylR structure subject to cleavage. This would expand considerably the number of logic 26 
gates that could be derived from XylR-targeted promoters and similar σ54-dependent TFs. Yet, the 27 
technical bottleneck for this endeavor is the identification of such permissive sites for implantation of a 28 
functional target for a specific protease within protein structure. The sections below describe the design 29 
of a synthetic tool tailored precisely to this end and its application to generate XylR variants endowed 30 
with the desired signal-processing capacities.  31 
 6 
 1 
Genetic grafting of protease-cleaving sites through the XylR structure. Since the permissiveness 2 
of protein structures to insertions of extra amino acid sequences is often difficult to predict upfront, we 3 
set out to develop a general molecular tool for searching such sites in any protein of interest to be 4 
grafted with any other functional polypeptide. To address this, we exploited the known mechanism of 5 
transposition of Tn518 for designing a high-efficiency mobile DNA segment that could first be delivered to 6 
the target DNA, selected for insertions and then excised to leave behind the grafted sequence. The 7 
organization of the synthetic mobile element engineered to this end, which we have termed mTn5 8 
[GFP•NIa1], is sketched in Fig. 2. A detailed description of its functional parts and its performance in 9 
vivo and in vitro can be found in the Supporting Information. Once the method for in vitro transposition of 10 
mTn5 [GFP•NIa1] into any target sequence was in place we carried on to generate a large library of 11 
insertions of this element through the xylR gene born by plasmid pBCL4. This was then followed by 12 
excision of much of the transposon length to leave behind a sequence scar encoding the short amino 13 
acid sequence cleaveable by the viral protease NIa. The workflow for generating such knock-in-leave-14 
behind (KILB) libraries is sketched in Fig. 3. The transposition reaction is predicted to introduce the 15 
mobile element throughout the whole plasmid i.e. both inside and outside the xylR sequence. 16 
Predictably, digestion of the transposition mix with enzymes BamHI and XbaI generated four restriction 17 
bands, which could be easily separated by means of electrophoresis in agarose gels (Supplementary 18 
Fig. S1). The product of the size of xylR plus one mTn5 [GFP•NIa1] insertion (3541 bp) was recovered 19 
and re-cloned in the same sites of the pUC18-SbfI plasmid pre-digested with BamHI and XbaI). This 20 
simple procedure allowed the recovery of the inserted xylR sequences only, as it discards transposition 21 
events occurring in vitro beyond the sequence of interest in the pBCL4 plasmid. The ligation pool was 22 
then transformed in E. coli, followed by selection on media with ApR KmR. The whole of transformants 23 
were pooled again and the total plasmid contents extracted from the mixed population. The plasmidic 24 
material was then digested with either NotI or SbfI and the digestion products re-ligated. Owing to the 25 
design of the synthetic transposon (Fig. 2), such an excision of the internal NotI or SbfI segments of 26 
mTn5 [GFP•NIa1] followed by religation leaves xylR DNA with in-frame fit-in insertions of either GFP or 27 
the NIa target polypeptide, respectively. One out of 6 of these inserts was predicted to create 28 
sandwiched gene fusions between xylR and either GFP or the proteolyzable peptide. If the sites of start 29 
and end of such grafted polypeptides in XylR happen to be structurally permissive we would then expect 30 
to have this TF artificially added in its structure with a new trait i.e. either fluorescence (because of the 31 
 7 
sandwiched GFP) or sensitivity to the NIa protease (due to the insertion of a cognate target site). XylR 1 
variants of both types were screened for functionality by transforming each pool in E. coli CC118 Pu-2 
lacZ. This strain has a chromosomal insertion of a reporter β-galactosidase gene to the σ54 promoter Pu 3 
that is activated by XylR in the presence of the aromatic inducer19. We in fact obtained a number of both 4 
XylR derivatives that were fluorescent and able to activate the cognate σ54 promoter Pu and others that 5 
were responsive to the NIa protease. The sections below, however, focus exclusively on the last 6 
category, as they are the ones that change the input/output logic of the regulator, as pursued in this 7 
work (see above).   8 
 9 
Analysis of NIa-tagged XylR variants. The negligible level of basal transcription of the Pu promoter 10 
under non-induced conditions (i.e. without XylR or with XylR but not m-xylene) made strain E. coli 11 
CC118 Pu-lacZ a phenomenal tool for examining the effect of the genetic grafts discussed above on 12 
XylR properties. The reference conditions for such functionality tests are shown in Supplementary Fig. 13 
S2. The lawns of plasmid-less E. coli CC118 Pu-lacZ (or the same strain transformed with insert-less 14 
vectors) are colorless when spotted on LB-Xgal plates. The same is true for E. coli CC118 Pu-lacZ 15 
transformed with the reference xylR+ plasmid pBCL4, which encodes the wild-type sequence of this TF 16 
–provided that the plates are not exposed to m-xylene. Exposure to this aromatic makes the lawns of E. 17 
coli CC118 Pu-lacZ (pBCL4) to turn intense blue. These visual phenotypes match exactly the levels of 18 
β-galactosidase that can be measured in liquid cultures of the same strains, as shown in 19 
Supplementary Fig. S2. Reporter readout in this system thus faithfully describes the functionality of XylR 20 
as an m-xylene responsive TF. 21 
 22 
Once the conditions to measure XylR activity were standardized, the KILB library of NIa-target 23 
insertions born by plasmid pBCL4 was transformed in E. coli CC118 Pu-lacZ, plated on LB-ApR and the 24 
resulting colonies exposed to saturating vapors of m-xylene as described in Methods. Out of a whole 25 
library of 2.7x103 clones, approximately 45 % turned blue under such conditions, suggesting that the 26 
extra in-frame polypeptide left in the protein structure by the KILB transposon had hit permissive sites of 27 
the protein structure. DNA sequencing of a randomly picked subset of ~ 50 clones indicated that not all 28 
permissive insertions had the proper orientation and/or the correct reading frame to generate productive 29 
NIa recognition sites within XylR.Finally, only four xylR clones inserted with NIa-sites were selected for 30 
further phenotypic analyses. Three of these NIa-site insertions were found at various places of the N-31 
 8 
terminal signal reception A module of the XylR protein (M75, G154 and D210) whereas a fourth one 1 
(E499) was located in the short linker that connects the central activation module C of the protein and 2 
the DNA-binding D domain. As shown in Fig. 4, insertions M75 and G154 were competent for induction 3 
of the Pu-lacZ fusion of the host, but originated lower β-galactosidase levels than the wild-type XylR 4 
when exposed to m-xylene. In contrast the NIa-target insertion at the very end of the A domain (D210) 5 
fashioned a XylR variant with a higher activity when induced with the same aromatic effector. A similar 6 
result was obtained with the NIa-targeted E499 XylR variant, which displayed a significantly higher Pu 7 
output when exposed to the protease in vivo (Fig. 4).  8 
 9 
The wild type-like behavior of insertions D210 and E499 did however change when the host reporter 10 
strain was made to express the NIa protease by means of plasmids encoding the cognate PPV gene. In 11 
the first case, insertion of the NIa recognition site at the end of the A domain of XylR (D210) led to Pu 12 
induction irrespective of the presence or the absence of the XylR inducer (m-xylene) when it was 13 
expressed along with the protease. This phenotype is consistent with that expected of a XylR∆A 14 
protein, as previously described12,13. That XylRD210 was cleaved by NIa in vivo could be visualized by 15 
means of a Western blot assay of protein extracts of the corresponding cells (Fig. 4b, lanes 7 and 8). 16 
Note that antibodies used to detect XylR were raised against the XylR∆A protein20 and therefore they 17 
do not recognize the A domain. Results equivalent to those of Fig. 4b were obtained when the Western 18 
blot test was made in the presence of m-xylene, i. e. the NIa protease appeared to proteolyze the XylR 19 
variants under examination with the same efficiency. These data thus accredited that XylRD210 can be 20 
converted into a TF form able to activate Pu by either exposure to m-xylene or by expression of the NIa 21 
protease or by both. This notion was further verified by reconstructing a XylR variant which had been 22 
deleted exactly of the same portion of the A domain that is predicted to be lost upon cleavage of 23 
XylRD210 with NIa (see below). 24 
 25 
A quite different behavior was found in the XylR variant inserted with a NIa site in position E499. In that 26 
case, expression of the protease translated in a virtually inactive TF regardless of whether m-xylene 27 
was present in the medium (Fig. 4). Western blots of the protein extracts as before confirmed that NIa 28 
indeed cleaved XylRE499 in vivo (Fig. 4b, lines 9 and 10). Since such a cleavage must result in the 29 
deletion of the DNA binding domain of XylR, it makes sense that the TF factor loses activity altogether. 30 
This last experiment also provided a sidelight in the mechanism of activation of Pu by XylR, since it 31 
 9 
makes clear that at least part of the D domain of the protein is essential not only for DNA binding but 1 
also for maintaining a form of the protein able to activate transcription from solution19, 21, 22. Finally, NIa 2 
target insertions at sites M75 and G154 resulted in XylR variants that could be cleaved in vivo as well 3 
(Fig. 4b, lines 3 to 6) but such site-specific proteolysis changed little the corresponding phenotypes 4 
regarding Pu induction. It is possible that such variants that were identified in the first visual screening 5 
(see above) are in fact defective or only transiently active TFs.  6 
 7 
The novel Boolean logic of XylRD210 and XylRE499. As shown in Fig. 5a, insertion of NIa target 8 
sequences in D210 and E499 sites of XylR endowed this TF with the capacity to compute two signals 9 
(m-xylene and protease) instead of the one-input/one-output observed in the naturally occurring 10 
regulator. In one case, XylRD210 brings about strong activation of the Pu promoter whether cells are 11 
exposed to the aromatic inducer, to NIa or both. This state of affairs can be formalized as a Boolean OR 12 
gate (Fig. 5b). It is noteworthy that promoter activity caused by cleavage of XylRD210 is noticeably higher 13 
than that of m-xylene and that the first overrides the second when the two are entered together (e.g., 14 
compare ß-galactosidase levels of cognate assays in Fig. 4c). This makes sense in view of the 15 
mechanism of activation of XylR by aromatic inducers12: the loss of the A domain leaves the TF 16 
unhindered for interacting with the σ54-dependent transcription machinery. A different logic gate was 17 
created by the insertion of a NIa site in XylRE499. In this instance, expression of the protease abolishes 18 
activation of the TF by m-xylene (Fig. 5). For Pu to be transcribed cells thus need to face the aromatic 19 
effector but must not be exposed to any proteolysis caused by NIa. The logic is therefore that of a 20 
Boolean ANDN gate1 in which one specific input must be present and the other absent to have a 21 
positive outcome of the computation. Note, however, that in the case discussed here, the inputs are not 22 
equivalent and their order of appearance makes a difference. In any case, the above manipulations of 23 
XylR expand the logic repertoire of this TF to additional signals that can result in either positive or 24 
negative outcomes.  25 
 26 
Pu promoter anti-activation: engineering a cleavable variant of XylR∆A. The inhibitory action of 27 
NIa on XylRE499 raised still one more possibility to develop a different logic gate based on this TF. Since 28 
the in vivo deletion of the D domain leads to an entirely inactive regulator (Fig. 4), we wondered whether 29 
introducing directly the NIa site in the constitutively active protein XylR∆A could reverse the action of 30 
this TF on Pu upon expression on the protease in vivo. To examine this possibility we produced a series 31 
 10 
of XylR∆A variants that carry various sequences at their N and C termini as shown in Fig. 6 (see details 1 
on the protein ends in Supplementary Fig. S3). The collection included as controls the original XylR∆A2 2 
protein of reference12,13 named SP1 in Fig. 6a) and a faithful reconstruction of the truncated product that 3 
is predicted to be released upon cleavage of XylRD210 with NIa (SP3 in Fig. 6). Each of these was then 4 
engineered with protease-cutting sites at position E499, originating cleavable protein variants SP2 and 5 
SP4 respectively (both designated as XylR∆A*). Finally, we recreated the polypeptide that could result 6 
from excision of the XylR protein at both D210 and E499 sites, which encompasses the whole C domain 7 
of the TF. Plasmids encoding each of these XylR variants were passed to E. coli Pu-lacZ strains 8 
expressing or not NIa and the production of the regulator examined in each condition. As shown in 9 
Supplementary Fig. S3, control variants SP1, SP3 and SP5 were not affected by NIa, while SP2 and 10 
SP4 were cleaved as expected. When the same strains were patched on Xgal plates, the change of 11 
color of variants SP2 and SP4 in the cells producing NIa became evident. These visual phenotypes are 12 
consistently reflected in the actual levels of the reporter product displayed by each of the constructs with 13 
and without protease as shown in Fig. 6c. The most dramatic change was delivered by the SP4 14 
variants, which passed from a high β-galactosidase level in the absence of protease (~2000 Miller units) 15 
to virtually undetectable in the strain that expressed NIa from plasmid pPPV1. Note that unlike full-16 
length XylR, the default action of XylR∆A is activation of Pu in the absence of any effector (a YES gate, 17 
Fig. 6d) and the effect of the protease is to defeat this event. The consequence of NIa expression is 18 
therefore to revert activation and thus suppress Pu activity. If expression of the cleavable XylR∆A 19 
variant is given a digital value of 1 then proteolysis can be formalized as an inverter in which NIa is the 20 
sole input. But if expression of XylR∆A* is also variable, then the resulting regulatory device becomes 21 
an ANDN gate with both NIa and the engineered TF as inputs (Fig. 6d). To the best of our knowledge, 22 
this is the first case of either a naturally occurring or an engineered biological inverter that is 23 
implemented through an anti-activation mechanism. Although the logic of such NOT device is the same 24 
than that brought about by a repressor1, the biological basis of the inversion is entirely different, what 25 
will surely be reflected in the parameters that govern the process in vivo. While such parameterization of 26 
this and the other regulatory devices described above will be the subject of future work, we expect these 27 
new gates based on XylR to enrich the choices available for construction of complex genetic and 28 
metabolic circuitry.  29 
 30 
 11 
Conclusion. The application of Boolean logic to a large number of biological phenomena has allowed 1 
both formalization of intricate occurrences in live systems16 and the engineering of genetic and 2 
metabolic devices for programming new-to-nature properties. The biological parts available for such 3 
engineering include transcriptional factors and cognate promoters1,5,6, recombinases23,24, metabolic 4 
reactions25-27, small molecules4,7,26 single cells28 and even multicellular networks29. The modularity of 5 
logic gates allows the buildup of a degree of multi-scale complexity that is limited only by the biological 6 
compatibility of the corresponding inputs and outputs6,28. On this basis, contemporary Synthetic Biology 7 
claims a similarity between genetic networks and electronic circuits that include not only discrete 8 
decision-making modules, but also whole operating systems30,31. Logic devices based on regulatory 9 
parts are typically implemented by combinations of transcriptional factors and small molecules that act 10 
as inputs in given promoters. DNA binding (or not) is, mechanistically, the event that mediates the 11 
corresponding computation. We show above that one family of prokaryotic TFs that act in concert with 12 
the σ54-containing form of RNAP can be functionalized with protease-cleaving sites in a fashion that 13 
makes the TF itself –not its binding to DNA, the performer of the binary computation. Prokaryotic TFs 14 
that process two equally effective inputs are thus far unknown in the transcription literature. Some 15 
regulators may use intermediate metabolites as allosteric effectors32,33 but their effects are mild as 16 
compared to the drastic change in Pu promoter output caused by the XylR variants described above. 17 
Moreover, we have not overlooked that the genetic tools described above for implementing the KILB 18 
insertion saturation procedure (transposons mTn5 [GFP•NIa1], mTn5 [GFP•NIa2] and mTn5 19 
[GFP•NIa3]) can be tailored á la carte for grafting functional sequences in permissive sites of virtually 20 
any other protein of interest. While the random insertion approach for sandwiching foreign polypeptides 21 
in existing proteins is not without precedents34-37, the work reported here is the first time that the 22 
concept is applied to transcriptional factors with a view on changing its regulatory behavior. In this 23 
respect, although the data presented in this paper deal only with the ability of XylR to activate Pu, Fig. 1 24 
shows also that the same TF represses its own promoter, PR. It is thus conceivable that the logic of the 25 
new gates based on XylRD210, XylRE499 and XylR∆A* (Fig. 5b and Fig. 6d) is reverted when the target 26 
promoter is PR instead of Pu. Alas, the degree of repression of PR by XylR is not strong enough to grant 27 
a performance as stringent as the one observed with Pu17). Still the binding of XylR to PR can be 28 
artificially improved, an issue that is currently under investigation. In sum, we argue the value of 29 
combining σ54-dependent TFs, cognate promoters, small molecules and proteases as a way of 30 
 12 
increasing the toolbox of logic devices that are necessary to build genetic and metabolic circuits of 1 
growing complexity e.g. for in situ biodegradation of toxic pollutants38. 2 
 3 
METHODS 4 
 5 
Strains, plasmids, media and growth conditions. The relevant properties of the strains and 6 
constructions used in this work are listed in Supplementary Table S1. E. coli DH10B, DH5α and CC118 7 
strains were used for general procedures. The reporter strain E. coli CC118 Pu-lacZ was used for 8 
assessing XylR activity. Bacteria were grown routinely at 37 ºC in LB (10 g l-1 of tryptone, 5 g l-1 of yeast 9 
extract and 5 g l-1 of NaCl). When required, ampicillin (Ap, 150 µg/ml), kanamycin (Km, 75 µg/ml) or 10 
chloramphenicol (Cm, 30 µg/ml) was added to the culture media. Isopropyl-β-D-thiogalactopyranoside 11 
(IPTG) was added where indicated to a final concentration of 0.1 mM. The Pu-lacZ fusion was induced 12 
by exposing cells either on plates or in liquid cultures to saturating vapors of m-xylene. When required, 13 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (Xgal) was added at 40 µg ml-1 for visualization of β-14 
galactosidase activity. 15 
 16 
DNA constructs. General methods for DNA manipulation were performed as described39. 17 
Oligonucleotides used in polymerase chain reaction experiments (PCR) are listed in Supplementary 18 
Table S2. Construction of a transposition target plasmid encoding xylR gene, involved two steps. First, 19 
the single SbfI site of pUC18 was eliminated by digestion with PstI followed by T4 DNA polymerase 20 
treatment and religation, resulting in vector pUC18-SbfI. Next, the DNA sequence of the xylR gene was 21 
amplified from strain P. putida mt-2 with oligos xylR-BamHI (containing an optimal RBS and a BamHI 22 
restriction site) and xylR-XbaI (which adds an XbaI site). The resulting fragment was cloned into a 23 
pGEM-T (Promega), excised with BamHI and XbaI and ligated into the corresponding sites of pUC18-24 
SbfI. This produced plasmid pBCL4, which was subsequently used as the target DNA in transposition 25 
experiments. The DNA segments that compose the KILB transposon used in this work were 26 
synthesized (Life Technologies, Regesnburg, Germany) and combined with a Km resistance gene 27 
amplified from plasmid pBAM1 cassette with primers Km-SwaI-Fan dKm-PshAI-R, which generate 28 
terminal SwaI and PshAI sites. The resulting segment, assembled in plasmid pGA-BCL1 29 
(Supplementary Table S1) bears the mini-Tn5 transposon named mTn5 [GFP•NIa1], the structure of 30 
which is drawn in Fig. 2a. For in vivo transposition experiments, the DNA spanning the whole mobile 31 
 13 
element was cloned as a PvuII fragment in the corresponding sites of plasmid pBAM1, thereby 1 
originating pBAM1-GFP (GenBank HQ908072). Two more versions of the same transposon were 2 
constructed -bearing either AscI or PmeI restriction sites in lieu of the SbfI sequences, thereby 3 
generating mTn5 [GFP•NIa2] and mTn5 [GFP•NIa3]. Details of their DNA assembly steps are available 4 
upon request. Plasmids expressing different XylRΔA truncated variants were constructed as follows. 5 
DNA segments encoding SP1 and SP2 -both deleted of their N-terminal domains as described for 6 
XylRΔA213 were amplified with primers DeltaA2F and M13 (-40) universal-F from plasmids pBCL4 (wt 7 
xylR gene) and pBCL4-E499 (xylRE499 variant), respectively. The resulting DNAs were then digested 8 
with BamHI and XbaI and cloned into the corresponding sites of pUC18, giving rise to pBCL4-SP1 and 9 
pBCL4-SP2. Other XylR∆A variants were made with an N-terminus that mimics the result of the 10 
cleavage of XylRD210 with the NIa protease. For SP3, the insert of plasmid pBCL4-D210 (encoding the 11 
xylRD210 variant obtained by KILB) was amplified with primers D210F and M13 (-40) universal-F, the 12 
resulting DNA digested with BamHI and XbaI and ligated into the corresponding sites of pUC18, raising 13 
pBCL4-SP3. In the case of SP4 and SP5, two PCR reactions were run in each case to obtain separate 14 
5´ and 3´ends in each case, followed by a second overlapping reaction using products from the first 15 
PCR as templates. The 5´ region, which was common to both SP4 and SP5 was amplified from pBCL4-16 
D210 with primers D210F and XylR-Sol.R. The 3´ portions were obtained by PCR of pBCL4-E499 17 
(encoding the xylRE499 variant obtained by KILB) with primers XylR-Sol.F and M13 (-40) universal-F -in 18 
the case of SP4 and XylR-Sol.F and E499stop-R in the case of SP5. Equivalent amounts of the 5´ DNA 19 
fragment together with each of the 3´ segments were used as templates for a second PCR reaction with 20 
primers D20F1 and M13 (-40) universal-F for full-length amplification of SP4 and D210F1 and 21 
E499stop-R for the same in SP5. The DNAs resulting from this reaction were then digested with BamHI 22 
and XbaI and ligated into the corresponding sites of pUC18, thereby originating pBCL4-SP4 and 23 
pBCL4-SP5. 24 
 25 
In vitro transposition and construction of knock-in-leave-behind (KILB) insertion libraries. A 26 
hyperactive variant of the Tn5 transposase was purified from plasmid pGRTYB35 (kindly provided by 27 
W.S. Reznikoff) as described40. The donor DNA segment spanning the mTn5 [GFP•NIa1] transposon 28 
was amplified from pGA-BCL1 with primers Tn5ME-F and Tn5ME-R. The amplified fragment was then 29 
gel purified with NucleoSpin Extract II kit (Macherey-Nagel), and kept until use. In vitro transposition 30 
experiments were set up as described41. The reactions were assembled in a volume of 10 µl of 31 
 14 
transposition buffer containing 0.1 µM purified transposase (0.1) and an equimolar amount of 1 
transposon and target DNA (ratio transposase:transposon:target DNA =  5:1:1). Reactions were 2 
incubated at 37ºC for two hours and then halted with 1 ml of stop solution (1% SDS), mixed and heated 3 
at 70ºC for 10 minutes. Next, the mixtures were dialyzed againstMilliQ water and electroporated into E. 4 
coli DH10B. The transformation mixture was then plated on LB Km (75 µg/ml) to select cells with 5 
plasmids that had acquired the mTn5 [GFP•NIa1] transposon (Fig. 3). The efficiency of the transposition 6 
reaction was measured as CFUs per pMol of mTn5 [GFP•NIa1] DNA. Next, the KmR clones were 7 
pooled, the whole plasmid DNA extracted and digested with BamHI and XbaI. This generated four 8 
restriction products that were separated with electrophoresis in agarose gels (Supplementary Fig. S1a). 9 
The band corresponding to the xylR gene with transposon insertions was recovered, re-cloned in 10 
pUC18-SbfI and retransformed in E. coli DH10B. Clones were pooled again, plasmid DNA extracted 11 
and separately digested with either NotI or SbfI and then religated (Supplementary Fig. S1b). As 12 
explained in Fig. 2, NotI digestion/religation creates in-frame sandwich GFP fusions, while the same 13 
with SbfI leaves the target gene sequence densely punctuated with in-frame insertions of the NIa 14 
protease target peptide (plus adjacent sequences inherited from the Tn5 ends, Fig. 2). The 15 
corresponding plasmid pool was recovered and transformed in reporter strain E. coli CC118 Pu-lacZ for 16 
XylR activity assays as explained next.  17 
 18 
Monitoring promoter activity in vivo. The ability of XylR and its variants to activate transcription from 19 
the σ54 promoter Pu was measured by quantifying the β−galactosidase accumulation driven by a Pu-20 
lacZ fusion engineered in the chromosome of E. coli CC11819. This reporter strain was transformed with 21 
the plasmids encoding xylR variants described above along, where indicated with plasmid pPPV142 or 22 
pPPVs2043 encoding the NIa protease. For the assays, cultures were pregrown overnight at 37ºC in LB 23 
medium with appropriate antibiotics, then diluted in fresh medium to an OD600 = 0.1 and grown with 24 
vigorous shaking up to mid-exponential phase (OD600 = 0.4-0.5). At that point flasks were added 0.1 mM 25 
IPTG and the incubation continued up to OD600 ~ 1.0. Cultures under scrutiny were then exposed to 26 
saturating vapors of the XylR effector (m-xylene) in airtight flasks and incubated further for 3 hours. β-27 
galactosidase levels were then determined in cells permeabilized with chloroform and SDS as described 28 
by44. The results shown represent a minimum of 3 experiments per each condition.  29 
 30 
 15 
Western blot analyses of XylR expression. The performance of the NIa protease to cleave XylR 1 
variants in vivo was diagnosed in bacteria from the cultures grown as described in the previous section. 2 
To this end, cells recovered by centrifugation were directly disrupted by boiling them for 7 min in a 3 
denaturing sample buffer containing 2% SDS and 5% β-mercaptoethanol. Samples were then run 4 
through 10% SDS-PAGE gels. Purified full-length 6xhisXylR and XylRΔA proteins kindly provided by C.A. 5 
Carreño and17, respectively, were used as controls. Polyacrylamide gels were subsequently blotted onto 6 
a polyvinylidene difluoride  (PVDF) Inmobilon-P membrane (Millipore) and probed with 1:2000 dilutions 7 
of an anti-XylR recombinant phage antibody PhaB B720. XylR bands were detected with anti-M13 8 
peroxidase conjugates as described and their location revealed by reaction with BM Chemiluminiscence 9 
Blotting Substrate (POD) from Roche (Mannheim, Germany). 10 
 11 
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FIGURES 1 
 2 
Figure 1. Functional organization and mode of action of the m-xylene responsive σ54-dependent 3 
regulator XylR.  4 
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 (a) Functional domains of XylR. The organization of the modules that compose this TF is shown with 8 
indication of the amino acid residues that define the limits between the functional domains and the 9 
localization of the relevant functions within the protein sequence: A (signal reception and inducer 10 
binding), B (interdomain linker region), C (binding and hydrolysis of ATP and contacts with the σ54-11 
 21 
RNAP) and D (including a helix turn helix motif, for binding to the UAS of the target promoter DNA). (b) 1 
Activation of XylR by m-xylene. The drawing sketches how the TF folds such that the N-terminal A 2 
domain hinders an activation surface of the regulator. Effector binding to the A domain releases such a 3 
intramolecular repression and XylR becomes then competent for interacting with the σ54-RNAP bound 4 
further downstream in Pu and activating transcription. The same XylR surface can be presented to the 5 
σ54-RNAP by deleting the whole A domain, thereby creating a effector-independent and constitutively 6 
active variant XylR∆A. (c) The Pu promoter region. The DNA segment of interest is expanded, showing 7 
the location of relevant sequences, including distal and proximal upstream binding sites for the XylR 8 
oligomer (UASd and UASp, respectively), the -12/-24 motif recognized by σ54-RNAP, and one 9 
integration host factor (IHF) binding site located within the intervening region. The logic of such an 10 
arrangement is an AND gate (inputs m-xylene and XylR) followed by a YES operator. If XylR has a 11 
default value of 1, then the regulatory node becomes a factual YES gate with m-xylene as input and 12 
transcription initiation as output (polymerase per second or PoPS). (d) The PR promoter region. XylR 13 
auto-regulates activity of this σ70-promoter which includes two overlapping initiation sites (PR1 and PR2). 14 
PR is repressed by XylR because the UAS of a second divergent σ70 promoter (Ps) overlap the two -10/-15 
35 sequences that drive divergent transcription of the xylR gene. The logic is thus the opposite of that of 16 
Pu: an AND gate followed by an inverter. As before, if XylR is present throughout, the node becomes a 17 
NOT gate with m-xylene as input and PoPS as output. 18 
 19 
20 
 22 
Figure 2. Design and properties of synthetic transposon mTn5 [GFP•NIa1].   1 
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(a) Physical and functional organization. This mobile element is composed by an array of DNA 5 
segments which are bracketed by the so-called Tn5 mosaic ends (ME), i.e. 19 terminal inverted repeats, 6 
optimized for hyperactive transposition and both concluding in half PvuII sites. The sequences (left to 7 
right in the sketch) between the two MEs ends include [i] a gfp gene (GFP) devoid of start and stop 8 
codons and bound by restriction sites for the 8-bp cutters SbfI and NotI, [ii] a kanamycin resistance 9 
cassette (KmR) flanked by unique restriction sites SwaI and PshAI (not shown) plus another SbfI and [iii] 10 
a 39 pb sequence encoding the peptide that is specifically recognized by the viral NIa protease followed 11 
 23 
by one more NotI site. Note the correlation between the two alternate SbfI and Not sites. (b) Generation 1 
of sandwiched in-frame GFP fusions. Digestion/religation of the transposon-inserted DNA with NotI 2 
deletes the Km resistance gene and the NIa target sequence, thereby generating a fusion with both the 3 
5’ and the 3’ ends of the gfp sequence, the boundaries of which are blown up in the sketch. (c) 4 
Knocking-in target peptides for the NIa protease. Digestion/religation of the same transposon-inserted 5 
DNA with SbfI excises the internal GFP/Km segment of mTn5 [GFP•NIa1] and leaves behind an in-6 
frame addition of the extended amino acid sequence recognized by NIa (in yellow). 7 
 8 
9 
 24 
Figure 3. Generation of knock-in-leave-behind (KILB) libraries.  1 
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(a) In vitro mutagenesis. The target gene is cloned in a plasmid as a BamHI-XbaI insert (in this 5 
example, sequences corresponding to the functional domains of xylR are indicated) and the DNA is 6 
used as the substrate of an in vitro mutagenesis reaction with mTn5 [GFP•NIa1] as detailed in the 7 
Materials and Methods section. (b) Recovery of inserted target sequences. The products of the 8 
transposition reaction are transformed in E. coli, KmR clones selected, pooled, their plasmids extracted 9 
 25 
and the DNA digested with BamHI and XbaI, what allows recovery of a pool of DNA segments with the 1 
xylR gene inserted randomly with mTn5 [GFP•NIa1]. This pool (see Supplementary Fig. S1) is then 2 
recloned in the BamHI / XbaI sites of the same vector, so that only inserts in the gene of interest are 3 
retained. (c) Generation of in-frame gene fusions. The ligation mixture is re-transformed and processed 4 
in E. coli as before (Supplementary Fig. S1b) and the plasmid pool digested and religated with either 5 
NotI (thereby creating in-frame sandwich GFP fusions) or with SbfI, that leaves a sequence scar that 6 
can be cleaved by the NIa protease. The successful production of such knocked-in protein variants can 7 
then be tested by transforming the plasmid pool in either plain E. coli CC118 and examining the plates 8 
with blue light (for GFP expression) or the reporter strain E. coli CC118 Pu-lacZ, the colonies of which 9 
turn blue upon exposure to vapors of the XylR effector m-xylene.  10 
 11 
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Figure 4. XylR variants knocked-in with NIa protease target sites.  1 
 2 
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(a) Insertion points of the NIa tag through the protein sequence. The modular organization of XylR is 5 
sketched with indication of the permissive locations where the peptide containing the NIa cleavage sites 6 
was delivered by the KILB procedure. (b) Expression and sensitivity to NIa protease of XylR variants in 7 
vivo. Equivalent amounts of crude protein extracts from E. coli cultures expressing the XylR types 8 
indicated along with NIa (or without protease, as specified) were run in a denaturing gel, blotted and 9 
 27 
developed with anti-XylR∆A antibodies. (c) Quantification of the activity of NIa-cleavable XylR variants. 1 
Cultures of E. coli CC118 Pu-lacZ strain with plasmids encoding each of the XylR types and the NIa 2 
protease were grown and exposed to m-xylene as explained in the Materials and Methods section. The 3 
diagram plots the accumulation of β-galactosidase after 3 hours of induction with or without the 4 
protease as indicated.  5 
 6 
7 
 28 
Figure 5. The logic of protease-cleavable XylR variants.  1 
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(a) The two inputs of proteolyzable XylR. The drawing represents how cleavage of XylR in alternative 5 
sites of the regulator’s structure is propagated into the transcriptional activity of the reporter Pu-lacZ 6 
fusion. (b) Visual display of Pu activation by NIa-cleavable XylR variants. The left part shows the growth 7 
of E. coli CC118 Pu-lacZ expressing the XylR types labeled to the side and NIa, spotted on LB plates 8 
with Xgal and exposed to saturating vapors of m-xylene as indicated. The logic gates brought about by 9 
XylR versions D210 (cleavage in position 210 of the amino acid sequence, deleting the A domain) and 10 
E499 (split by NIa in 499 and excising the D domain) are shown to the right. Wild-type XylR operates as 11 
a YES (buffer) gate with m-xylene (X) as the only input. XylRD210 produces an OR gate with both m-12 
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xylene and NIa protease (N) as inputs. Finally, XylRE499 generates an ANDN device, where Pu activity is 1 
on only when one of the inputs is present (X) and the other is absent (N).  2 
 3 
4 
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Figure 6. The logic or anti-activation of Pu by XylR∆A* variants.  1 
 2 
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(a) Organization of the ∆A versions of XylR in respect to the full-length protein and its NIa-cleavable 5 
forms. The upper sketch shows a reference with the sites of the two NIa cutting sites at positions D210 6 
and E499. The synthetic ∆A proteins (SP) below are aligned in respect to such reference with indication 7 
of the amino acids that lead the N-terminus and the presence or not of an engineered E499 site. The 8 
amino acid sequence of the C-terminus of the SP5 protein variant (XylR∆A∆C) is blown up as well (see 9 
Supplementary Fig. S3 for more details on the amino acid termini of each protein). (b) E. coli CC118 10 
Pu-lacZ expressing each of the ∆A XylR types plus minus NIa as indicated and spotted on LB plates 11 
with Xgal. (c) Quantification of the activity of ∆A XylR variants. E. coli CC118 Pu-lacZ with plasmids 12 
encoding each of the XylR types were grown and NIa expression induced with IPTG. The protease was 13 
expressed through two alternative plasmids (pPPV1 and pPPSV20, Supplementary Table S1) as 14 
indicated. The graph shows accumulation of β-galactosidase after 3 hours of induction (see expression 15 
 31 
and cleavage of each of the XylR∆A variants in vivo in Supplementary Fig. S3). (d) Formalization of the 1 
regulatory behavior of NIa-cleavable XylR∆A variants as a digital gate. The logic of Pu activation by 2 
XylR∆A is a YES gate where the TF is the input and PoPS the output. In contrasts, SP3 and SP3 3 
versions of the same regulator generate an ANDN device, where Pu activity is on when the ∆A protein 4 
is present and the protease is absent. If such ∆A TFs are given a default value of 1, the same device 5 
becomes an inverter in which the only input is NIa.  6 
7 
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SUPPLEMENTARY INFORMATION 1 
 2 
Structure and modus operandi of the synthetic KILB transposon mTn5 [GFP•NIa1] 3 
 4 
The mobile element employed in this work for the knock-in-leave-behind (KILB) procedure adopted in 5 
this work has a total size of 1774 bp and allows generation of comprehensive libraries of either in-frame, 6 
sandwiched fusions to the green fluorescent protein (GFP) or specific cleavage sites recognized by the 7 
plant viral protease NIa (García et al, 1989a). Note that such NIa target sequence (NVVVHQA) is absent 8 
from the proteome of E. coli and therefore the duo NIa protease-NIa tagging peptide can be considered 9 
an orthogonal device. The engineering of the two cargoes in the same DNA segment allows an 10 
estimation of the efficiency of the transposition process as discussed below. The salient features of 11 
mTn5 [GFP•NIa1] include the following characteristics. First, the mobile element is flanked by optimized 12 
19 bp inverted repeats (mosaic ends or ME) that are recognized by the Tn5 transposase (Goryshin et al, 13 
1998). Such recognition catalyzes random insertion of mTn5 [GFP•NIa1] into target DNA through a 14 
process that results of duplication of the 9 bp adjacent to the transposition site (Reznikoff, 2008). Next to 15 
the ME left sequence (ME-L), mTn5 [GFP•NIa1] contains a leaderless gfp gene variant that is optimized 16 
for prokaryotic gene fusions to GFP (Miller and Lindow, 1997). Since the gfp sequence lacks a start 17 
codon, it should only be translated when inserted within another protein coding sequence in the right 18 
orientation and reading frame. mTn5 [GFP•NIa1] insertions that fulfill these conditions can be easily 19 
identified for fluorescence emission with the naked eye under blue light. Note also that gfp gene of 20 
mTn5 [GFP•NIa1] is flanked by an upstream SbfI site and a downstream NotI site. This is followed by a 21 
kanamycin resistance (KmR) gene (aminoglycoside phosphotransferase, aphA), which is instrumental for 22 
selecting transposition events in a wide range of Gram-negative bacteria. The DNA sequence of aphA 23 
(the expression of which is driven by its own promoter) was edited to improve codon usage and to 24 
eliminate naturally occurring SmaI and HindIII sites that could interfere with subsequent cloning 25 
procedures (Martinez-Garcia et al, 2011a). Furthermore, aphA was also flanked by restriction sites that 26 
follow the Standard European Vector Architecture (SEVA) format (Silva-Rocha et al, 2013)in such a way 27 
that this module can be easily exchanged by any other available marker of the collection (e.g. bla, cat, 28 
aadA, tet, aacC1). Finally, the aphA gene born by mTn5 [GFP•NIa1] is followed by a short DNA 29 
sequence that encodes the core peptide NVVVHQA that is specifically recognized by the NIa protease 30 
of a plant potyvirus (García et al, 1989b) added with three flanking residues at each side (Laín et al, 31 
 34 
1989). This was arranged in such a way that the NIa site was delimited by an upstream SbfI site and a 1 
downstream NotI site, next to which the mTn5 [GFP•NIa1] ends with the right ME sequence (ME-R) of 2 
the mobile element. The alternative tandem arrangement of framed SbfI and NotI sites in mTn5 3 
[GFP•NIa1] allows later excision of much of the inserted transposon after delivery of the mobile element 4 
to the target DNA sequence. This leaves in-frame, fit-in GFP or NIa- sequences sandwiched throughout 5 
the substrate DNA as described below. Finally, note that either boundary of mTn5 [GFP•NIa1] ends with 6 
a half PvuII site within the most external ME sequences. These are intended to ease the cloning and 7 
cutting out of the mobile segment in/from the cloning vectors (Supplementary Table S1) as needed for in 8 
vivo or in vitro transposition reactions. Two variants of the GFP•NIa -containing transposon were also 9 
added to the toolbox (see Materials and Methods section in main text) in which both SbfI sites were 10 
replaced by either AscI (resulting in mTn5 [GFP•NIa2]) or by PmeI (same, mTn5 [GFP•NIa3]). The 11 
validation of these tools and their exploitation for creating conditionally proteolizable variants of XylR is 12 
explained next.  13 
 14 
Testing mTn5 [GFP•NIa1] transposition 15 
 16 
The transposon described above was first verified for the functionality of all parts embedded in its 17 
design. To this end, the DNA sequence spanning the whole mTn5 [GFP•NIa1] segment was assembled 18 
as a PvuII fragment in the backbone of the suicide transposon delivery plasmid pBAM1 (Martinez-19 
Garcia et al, 2011a) that encodes both conjugal transfer functions and the Tn5 transposase protein 20 
TnpA. In vivo mobilization and transposition assays (Martinez-Garcia et al, 2011a) followed by selection 21 
of KmR exconjugants and inspection of green fluorescent colonies suggested the synthetic transposon 22 
to work at a frequency of 2.6 ± 0.1 x 103 , creating productive translational GFP fusions at a rate of 1.17 23 
± 0.1 x 10-3 (not shown). Delivering of the same mTn5 [GFP•NIa1] segment to E. coli by transformation 24 
of a preassembled transposome (Goryshin et al, 2000) increased the frequency of both events 25 
(insertion and production of chromosomal GFP fusions) by 10-fold. While these results accredited the 26 
performance of the engineered transposon, the relatively low numbers discouraged its use in vivo and 27 
advised instead adoption of an all-in vitro, high insertional density alternative. For this we set up a 28 
method with three purified components i.e. the mTn5 [GFP•NIa1], a hyperactive variant of the TnpA 29 
transposase (purified from expression plasmid pGRTYB35, see Materials and Methods) and the target 30 
DNA. The last is plasmid pBCL4, consisting of plasmid vector pUC18deleted of the SbfI site and 31 
 35 
carrying the xylR sequence as a BamHI-XbaI restriction fragment. In vitro reactions were optimized for 1 
maximizing the efficiency of transposon insertions. For this, the mTn5 [GFP•NIa1] element was entered 2 
in the reaction mix either as DNA fragment spanning exclusively the sequences bound by the Tn5 ends 3 
or as part of the supercoiled or else linearized pBAM1-GFP plasmid (Martinez-Garcia et al, 2011a). 4 
Similarly, the target DNA was brought into the system either as a supercoiled or a linearized plasmid (in 5 
this last case, followed by a ligation of the transposition products, see below). The efficiency of each of 6 
the combinations could be easily quantified by transforming the transposition mixture in E. coli and 7 
selecting for ApR KmR. These tests revealed that the best insertion rates were brought about by using 8 
the very mTn5 [GFP•NIa1] DNA segment as the transposon donor to the xylR-encoding supercoiled 9 
plasmid (5 x 105 ApR KmR c.f.u / pmol DNA mix), much above using pBAM1-GFP (4.3 x 104 c.f.u / pmol 10 
DNA) or its linearized version (8.2x104 c.f.u / pmol DNA). The scenario was thus set for the generation 11 
of high-density knock-in / leave behind (KILB) libraries of protease-target sites through the sequence of 12 
xylR along the lines explained in the rationale above.  13 
 14 
15 
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SUPPLEMENTARY TABLES 1 
 2 
Supplementary Table S1. Strains and plasmids used in this study 3 
 4 
Strain or plasmid Description References 
and/or source 
E. coli strains   
DH10B F- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 
Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-
hsdRMS-mcrBC)  λ- 
Invitrogen 
DH5α supE44, ΔlacU169, (φ80 lacZΔM15), hsdR17, (rk-mk+), 
recA1, endA1, thi1, gyrA, relA 
Invitrogen 
CC118 F-, Δ(ara-leu)7697, araD139, Δ(lac)X74, phoAΔ20, 
galE, galK, thi, rpsE, rpoB, argE(Am), recA1 
Manoil and 
Beckwith, 1985 
CC118 Pu-lacZ CC118 strain with a chromosomal Pu-lacZ 
transcriptional fusion assembled within a streptomycin 
resistance mini-transposon. 
de Lorenzo et al, 
1991 
P. putida strains   
mt-2 
(ATCC33015) 
Wild-type P. putida strain carrying TOL plasmid pWW0 Williams and 
Murray, 1974; 
Worsey and 
Williams, 1975 
Plasmids   
pGEM-T ApR, Cloning vector Promega 
pUC18 ApR, oriV ColE1, cloning vector Vieira and 
Messing, 1982; 
Yanisch-Perron 
et al, 1985 
pUC18-SbfI pUC18 derivative lacking PstI/SbfI sites This work 
pBCL4 pUC18-SbfI derivative with BamHI/XbaI fragment 
encoding xylR gene  
This work 
 37 
pMS-RQ SpR, oriColE1 cloning vector GeneArt® 
pGA-BCL1 
 
pMS-RQ derivative harboring mTn5 [GFP•NIa1]  
transposon at SfiI site 
This work 
pBAM1 ApR, oriR6K, oriT, tnpA, mini-Tn5 carrying a KmR gene. 
GenBank HQ908071 
Martinez-Garcia 
et al, 2011b 
pBAM1-GFP pBAM1 derivative harboring mTn5 [GFP•NIa1]  
transposon inserted in PvuII site. GenBank HQ908072 
Martinez-Garcia 
et al, 2011b 
pGA-BCL2 pMS-RQ derivative harboring mTn5 [GFP•NIa2]  
transposon at SfiI site 
This work 
pGA-BCL3 pMS-RQ derivative harboring mTn5 [GFP•NIa3]  
transposon at SfiI site 
This work 
pBCL4-M75 pBCL4 with xylR gene inserted with NIa sequence after 
M75 residue (xylRM75) by transposition with mTn5 
[GFP•NIa1]  
This work 
pBCL4-G154 pBCL4 with xylR gene inserted with NIa sequence after 
G154 residue (xylRG154) by mTn5 [GFP•NIa1]  
transposition 
This work 
pBCL4-D210 pBCL4 with xylR gene inserted with NIa sequence after 
D210 residue (xylRD210) by mTn5 [GFP•NIa1]  
transposition 
This work 
pBCL4-E499 pBCL4 with xylR gene inserted with NIa sequence after 
E 499 residue (xylRE499) by mTn5 [GFP•NIa1]  
transposition 
This work 
pBCL4-SP1 pUC18 derivative containing BamHI/XbaI fragment 
enconding SP1 XylR variant 
This work 
pBCL4-SP2 pUC18 derivative containing a BamHI/XbaI fragment 
enconding SP2 XylR variant 
This work 
pBCL4-SP3 pUC18 derivative containing a BamHI/XbaI fragment 
enconding SP3 XylR variant 
This work 
pBCL4-SP4 pUC18 derivative containing a BamHI/XbaI fragment 
enconding SP4 XylR variant 
This work 
 38 
pBCL4-SP5 pUC18 derivative containing a BamHI/XbaI fragment 
enconding SP5 xylR variant 
This work 
pPPVs20 pSU8 derivative containing the SalI-PstI fragment of 
PPV cDNA consisting of the 3´terminal region from nt 
3627 
Garcia et al, 
1989 
pPPV1 pVTR-B plasmid containing 0.6 Kb StuI-HindIII fragment 
encoding PPV NIa protease from pPPVs20 plasmid 
Perez-Martin et 
al, 1997 
 1 
 2 
3 
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Supplementary Table S2: primers used in the PCR reactions a) 1 
 2 
Oligonucleotide Sequence 
Tn5ME-F CTGTCTCTTATACACATCTCCTG 
Tn5ME-R CTGTCTCTTATACACATCTGCGG 
xylR-BamHI ATGGATCCAAGAGGAAAACAAATGTCGC 
xylR-XbaI GTTCTAGACTATCGGCCCATTGCTTTC 
Km-SwaI-F CGCGCGATTTAAATTTGTGTCTCAAAATCTCTGATGTTA 
Km-PshAI-R CGCGCGGACCGCGGTCCAATTAATTATTAGAAAAATT 
KpnI-AscI(1)-F CGCATGGTACCCAGCTGTCTCTTATACACATCTGGCGCGCCAGTAAAGGAGAAGAACTTTTCAC 
KpnI-PmeI(1)-F CGCATGGTACCCAGCTGTCTCTTATACACATCTGTTTAAACAGTAAAGGAGAAGAACTTTTCAC 
AscI(2)-F CTAATAATTAATTGGACCGCGGTCCGCGCGGGCGCGCCGGTGAAAGCAACGTGGTGGTG 
PmeI(2)-F CTAATAATTAATTGGACCGCGGTCCGCGCGGTTTAAACGGTGAAAGCAACGTGGTGGTG 
ApaLI-R GGGTTCGTGCACACAGCCCAGCTTGGAGCGAAC 
DeltaA2-F CCCGGGGATCCAAGAGGAAAACAAATGGAATTTCTGAAGCAGTACGATGGGCAG 
D210F GATAGGATCCAAGAGGAAAACAAATGGCGGATGAACGCGCGGCCGCAG  
D210F1 GATAGGATCCAAGAGGAAAACAAATG 
XylR-Sol.F GAGCGCGGGGTGATTCTTACCGAGAG  
XylR-Sol.R CTCTCGGTAAGAATCACCCCGCGCTC 
E499stop-R GATATCTAGACTACGCCTGATGCACCACCACGTTGCTTTC  
 3 
a) Sequences of oligonucleotides employed in this study. Restriction sites entered for cloning purposes 4 
are underlined. Sequences corresponding to mutations are indicated in italics. 5 
 6 
 7 
 8 
 9 
 10 
11 
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SUPPLEMENTARY FIGURES 1 
 2 
Supplementary Figure S1. Agarose gel analysis of DNA intermediates during KILB insertion saturation 3 
of a targer gene with mTn5 [GFP•NIa1].  4 
 5 
 6 
 7 
 8 
 9 
The figure shows two key steps of the process. Panel (a) illustrates the patter of the 4 DNA products 10 
that result from digesting a plasmid with the gene of interest (xylR in this case) with XbaI and BamH (the 11 
sites that flank the cloned gene) following saturation insertions with mTn5 [GFP•NIa1] in vitro and 12 
recovery of plasmids (see main text for explanation). The pool of same-size DNA fragments with the 13 
xylR gene densely punctuated with transposon insertions appears clearly separated from the rest of the 14 
DNA segments: inserted plasmid backbone, non-inserted counterpart and non-inserted xylR. Panel (b) 15 
shows the excision of most of the mTn5 [GFP•NIa1] insert from the xylR sequences by digestion of the 16 
cognate plasmids with SbfI. Religation of the DNA of the upper DNA band of the gel generates an in-17 
frame library of XylR variants inserted with cutting sites for protease NIa. Alternative digestion with NotI 18 
would have similarly created a library of GFP sandwiched in-frame fusions (not shown).  19 
 20 
21 
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 1 
Supplementary Figure S2. Regulatory phenotypes of XylR-encoding and NIa protease-encoding 2 
plasmids and cognate insertless vectors. 3 
 4 
 5 
 6 
 7 
 (a) E. coli CC118 Pu-lacZ expressing XylR and NIa through the plasmids indicated (Supplementary 8 
Table S1) and spotted on LB plates with Xgal and exposed or not to saturating vapors of m-xylene. (b) 9 
Reference values of Pu activity. Liquid cultures of E. coli CC118 Pu-lacZ transformed with plasmids 10 
encoding XylR and NIa protease and their vectors were grown and exposed to m-xylene as explained in 11 
the Materials and Methods section. The diagram shows the levels of β-galactosidase detected after 3 12 
hours of induction. 13 
 14 
15 
 42 
Supplementary Figure S3. Organization and in vivo expression of NIa-cleavable XylR and XylR∆A 1 
variants.  2 
 3 
 4 
 5 
(a) Detail of the amino acid sequences delivered to permissive sites of the XylR structure upon insertion 6 
saturation of the xylR gene with the KILB procedure. The scheme shows the location of the various NIa 7 
cutting sites with an indication of the new sequences introduced in each case: native XylR amino acids 8 
in bold, transposition scar sequences entered by the trace of the Tn5 termini in plain (capital) letters and 9 
the peptide targeted by the NIa protease in red. (b) Blowup of the C- and N-termini of synthetic ∆A 10 
proteins (SP) engineered or not with a NIa cleavage site. The amino acid sequence of the C-terminus of 11 
the SP5 protein variant (XylR∆A∆C) is blown up as well (color and letter codes same than before). (c) 12 
Expression and sensitivity to NIa protease of SP XylR variants in vivo. Equivalent amounts of crude 13 
 43 
protein extracts from E. coli cultures expressing the proteins indicated along with NIa (or without 1 
protease, as specified) were run in a denaturing gel, blotted and developed with anti-XylR∆A antibodies. 2 
 3 
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